Medicated Skin Care in Taiwan
Euromonitor International's Medicated Skin Care in Taiwan market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 39 | Publication date: Dec 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
OTC HEALTHCARE IN TAIWAN : MARKET INSIGHT
EXECUTIVE SUMMARY
New government policies advocate self-medication
Vitamins and dietary supplements records the best performance
Growing interest in herbal OTC products
Price increase across most OTC products
Companies seek a more professional image
KEY TRENDS AND DEVELOPMENTS
High merger and acquisition activity among multinationals
New NHI system to advocate self-medication
VDS and Chinese Herbal Medicine limit OTC growth potential
Rising presence of private label in leading hypermarkets and drugstores
Chained drugstores most active in outlet marketing
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - TAIWAN
CHINA CHEMICAL & PHARMACEUTICAL CO LTD - OTC HEALTHCARE - TAIWAN
STRATEGIC DIRECTION
KEY FACTS
Summary 2 China Chemical & Pharmaceutical Co Ltd: Key Facts
Summary 3 China Chemical & Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 4 China Chemical & Pharmaceutical Co Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 5 China Chemical & Pharmaceutical Co Ltd: Competitive Position 2006
GRAPE KING ENTERPRISE INC - OTC HEALTHCARE - TAIWAN
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Grape King Enterprise Inc: Key Facts
Summary 7 Grape King Enterprise Inc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 8 Grape King Enterprise Inc: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 9 Grape King Enterprise Inc: Competitive Position 2006
HSIN WAN JEN CHEMICAL & PHARMACEUTICAL CO LTD - OTC HEALTHCARE - TAIWAN
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Hsin Wan Jen Chemical & Pharmaceutical Co Ltd: Key Facts
Summary 11 Hsin Wan Jen Chemical & Pharmaceutical Co Ltd: Operational Indicators*
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 Hsin Wan Jen Chemical & Pharmaceutical Co Ltd: Competitive Position 2006
U CHU PHARM CO LTD - OTC HEALTHCARE - TAIWAN
STRATEGIC DIRECTION
KEY FACTS
Summary 13 U Chu Pharmaceutical Co Ltd: Key Facts
Summary 14 U Chu Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 U Chu Pharmaceutical Co Ltd: Competitive Position 2006
YUNG SHIN GROUP - OTC HEALTHCARE - TAIWAN
STRATEGIC DIRECTION
KEY FACTS
Summary 16 Yung Shin Group: Key Facts
Summary 17 Yung Shin Group: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 18 Yung Shin Group: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 19 Yung Shin Group: Competitive Position 2006
MEDICATED SKIN CARE IN TAIWAN
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 14 Herbal vs Standard Medicated Skin Care 2001/2006
Table 15 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 16 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 17 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 18 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 19 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 20 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011